NCT06208917View on ClinicalTrials.gov

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

PHASE3RecruitingINTERVENTIONAL

Enrollment

376

Participants

Timeline

Start Date

July 9, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

January 31, 2027

Conditions

Pediatric Solid Tumor, Unspecified, Protocol Specific

Interventions

DRUG

Ondansetron (Oral soluble film OR injections) ,Dexamethasone

Participants will randomly assigned 1:1 to receive treatment (Oral soluble film of Ondansetron plus dexamethasone OR Ondansetron injections plus dexamethasone).

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Yizhuo Zhang

OTHER